Welcome to our dedicated page for Tarsus Pharmaceuticals SEC filings (Ticker: TARS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tarsus Pharmaceuticals, Inc. filings document operating results, product commercialization, pipeline disclosures, governance matters, and capital-market reporting for a Nasdaq-listed biopharmaceutical company. Form 8-K reports include quarterly and annual financial results, XDEMVY net product sales commentary, corporate presentations, and clinical or commercial business updates involving TP-04 and TP-05.
Proxy and governance filings describe board composition, committee assignments, director elections, executive compensation, auditor ratification, stockholder voting results, and related compensation policies. The filing record also includes material-event disclosures for board appointments, Regulation FD presentations, common-stock voting matters, and formal disclosure of risk, oversight, and governance subjects relevant to Tarsus' commercial-stage pharmaceutical business.
TARS submitted a Form 144 to sell 2,186 shares of Common stock. The notice lists Fidelity Brokerage Services LLC as broker with a sale date of 03/19/2026. The filing also shows a restricted stock vesting event on 03/18/2026 for 2,186 shares and prior reported sales of 2,111 and 2,133 on 03/17/2026
Aziz A. Mottiwala files a Form 144 notifying a planned sale of 4,440 shares of Common Stock. The filing links the shares to restricted stock vesting dated 03/18/2026 and records two recent dispositions: 4,286 shares on 03/17/2026 and 4,330 shares on 03/18/2026.
The Form 144 names Fidelity Brokerage Services LLC as the broker-dealer. The filing characterizes the 4,440 shares as compensation-related restricted stock that vested on 03/18/2026.
TARS filed a Form 144 reporting proposed sales tied to recently vested restricted common stock and recent dispositions by an insider. The filing lists 11,964 shares associated with restricted stock vesting on 03/18/2026 and shows prior sales by Bobak Azamian of 10,972 shares on 03/17/2026 and 11,667 shares on 03/18/2026, with dollar amounts shown alongside each sale.
Dianne C. Whitfield filed a Form 144 reporting proposed sales of Common Stock. The filing lists three transactions: 15,565 shares on 01/02/2026 (proceeds $1,255,687.45), 4,029 shares on 03/17/2026 (proceeds $279,671.82), and 4,071 shares on 03/18/2026 (proceeds $279,717.60).
The broker on the notice is Fidelity Brokerage Services LLC. The filing includes a separate line noting Restricted Stock Vesting dated 03/18/2026.
TARS filed a Form 144 reporting proposed sale of 4,231 shares of Common Stock. The filing also records recent dispositions by Bryan Wahl of 4,084 shares on 03/17/2026 and 4,125 shares on 03/18/2026, with dollar entries of 283,489.63 and 283,427.93 respectively.
The notice lists a brokerage holder, Fidelity Brokerage Services LLC, and identifies a 03/18/2026 restricted stock vesting classified as Compensation. This Form 144 is a routine disclosure of intended resale under Rule 144 and related recent insider dispositions.
TARS filed a Form 144 reporting proposed sales of Common Stock by a reporting person. The filing lists 4,589 shares to be sold following a restricted stock vesting on 03/18/2026 as compensation. It also discloses prior sales in March: 8,366, 3,125, and 3,610 shares with associated proceeds reported.
TARS reported a Rule 144 notice for the proposed sale of 390 shares of Common Stock tied to a restricted stock vesting on 03/18/2026. The filing lists prior short-term transactions by Elizabeth Yeu-Lin: 375 shares on 03/17/2026 and 379 shares on 03/18/2026.
The filing identifies Fidelity Brokerage Services LLC as the broker and labels the 390-share entry as compensation-related (restricted stock vesting). This notice is an administrative disclosure of an intended resale under Rule 144.
Dianne C. Whitfield filed a Form 144 notice to sell 4,071 shares of Common Stock. The shares are tied to restricted stock vesting dated 03/17/2026 and are listed with Fidelity Brokerage Services LLC as broker. The filing also discloses prior dispositions of 15,565 shares on 01/02/2026 and 4,029 shares on 03/17/2026.
Bryan Wahl filed a Form 144 to offer 4,125 shares of Common Stock. The filing links the shares to a restricted stock vesting event dated 03/17/2026 and lists Fidelity Brokerage Services LLC as the broker. The filing also shows recent activity of 4,084 shares sold on 03/17/2026 and includes adjacent amounts $283,427.93 and $283,489.63.
Bobak Azamian reports proposed sale of common stock under Rule 144. The filing lists 11,667 common shares associated with Fidelity Brokerage Services LLC on 03/18/2026. The filing also discloses a prior sale of 10,972 shares on 03/17/2026 for $761,618.09.
The securities to be sold are listed as resulting from restricted stock vesting and are labeled compensation on 03/17/2026. Timing and exact sale methods are not detailed in the excerpt.